SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-010658
Filing Date
2018-05-03
Accepted
2018-05-03 16:02:06
Documents
45
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q odt-10q_20180331.htm 10-Q 525325
2 EX-31.1 odt-ex311_111.htm EX-31.1 17007
3 EX-31.2 odt-ex312_110.htm EX-31.2 17012
4 EX-32.1 odt-ex321_109.htm EX-32.1 15194
  Complete submission text file 0001564590-18-010658.txt   1932961

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT odt-20180331.xml EX-101.INS 262635
6 XBRL TAXONOMY EXTENSION SCHEMA odt-20180331.xsd EX-101.SCH 25233
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE odt-20180331_cal.xml EX-101.CAL 18457
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE odt-20180331_def.xml EX-101.DEF 43753
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20180331_lab.xml EX-101.LAB 172476
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20180331_pre.xml EX-101.PRE 124881
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38318 | Film No.: 18803666
SIC: 2834 Pharmaceutical Preparations